The price of Mersana Therapeutics Inc (NASDAQ: MRSN) closed at $5.04 in the last session, up 0.70% from day before closing price of $5.01. In other words, the price has increased by $+0.03 from its previous closing price. On the day, 7277473 shares were traded.
Ratios:
We take a closer look at MRSN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.36 and its Current Ratio is at 3.36. In the meantime, Its Debt-to-Equity ratio is 0.92 whereas as Long-Term Debt/Eq ratio is at 0.77.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wedbush on February 29, 2024, Upgraded its rating to Outperform and sets its target price to $7 from $2 previously.
On February 29, 2024, Guggenheim Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $7.
BTIG Research Upgraded its Neutral to Buy on February 29, 2024, while the target price for the stock was maintained at $6.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 16 ’24 when Protopapas Anna sold 29,399 shares for $2.71 per share. The transaction valued at 79,671 led to the insider holds 125,153 shares of the business.
Lowinger Timothy B sold 10,409 shares of MRSN for $28,208 on Jan 16 ’24. The SVP, Chief Sci.&Tech. Officer now owns 199,329 shares after completing the transaction at $2.71 per share. On Jan 16 ’24, another insider, DeSchuytner Brian, who serves as the SVP, COO & CFO of the company, sold 9,327 shares for $2.71 each. As a result, the insider received 25,276 and left with 54,511 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRSN now has a Market Capitalization of 607.12M and an Enterprise Value of 431.67M. For the stock, the TTM Price-to-Sale (P/S) ratio is 16.59 while its Price-to-Book (P/B) ratio in mrq is 16.49. Its current Enterprise Value per Revenue stands at 11.71 whereas that against EBITDA is -2.60.
Stock Price History:
Over the past 52 weeks, MRSN has reached a high of $9.62, while it has fallen to a 52-week low of $0.80. The 50-Day Moving Average of the stock is 3.93, while the 200-Day Moving Average is calculated to be 2.76.
Shares Statistics:
According to the various share statistics, MRSN traded on average about 2.14M shares per day over the past 3-months and 2.98M shares per day over the past 10 days. A total of 120.71M shares are outstanding, with a floating share count of 91.80M. Insiders hold about 24.32% of the company’s shares, while institutions hold 71.11% stake in the company. Shares short for MRSN as of Feb 29, 2024 were 7.14M with a Short Ratio of 3.33, compared to 6.65M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.89% and a Short% of Float of 6.41%.
Earnings Estimates
The company has 7 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.18 for the current quarter, with a high estimate of -$0.13 and a low estimate of -$0.21, while EPS last year was -$0.52. The consensus estimate for the next quarter is -$0.18, with high estimates of -$0.13 and low estimates of -$0.22.
Analysts are recommending an EPS of between -$0.25 and -$0.87 for the fiscal current year, implying an average EPS of -$0.65. EPS for the following year is -$0.67, with 7 analysts recommending between -$0.33 and -$0.91.
